Decreased vascular endothelial growth factor response to acute hypoglycemia in type 2 diabetic patients with hypoglycemic coma.
Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.
Fayfman M, Pasquel FJ, Umpierrez GE.
Med Clin North Am. 2017 May;101(3):587-606. doi: 10.1016/j.mcna.2016.12.011.
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.
Umpierrez G, Korytkowski M.
Nat Rev Endocrinol. 2016 Apr;12(4):222-32. doi: 10.1038/nrendo.2016.15. Epub 2016 Feb 19.
Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Mustafa OG, Haq M, Dashora U, Castro E, Dhatariya KK; Joint British Diabetes Societies (JBDS) for Inpatient Care Group.
Diabet Med. 2023 Mar;40(3):e15005. doi: 10.1111/dme.15005. Epub 2022 Dec 21.
Hyperosmolar Hyperglycemic State.
Stoner GD.
Am Fam Physician. 2017 Dec 1;96(11):729-736.
[Acute diabetic complications attended in a hospital emergency department: a descriptive analysis].
Sanz-Almazán M, Montero-Carretero T, Sánchez-Ramón S, Jorge-Bravo MT, Crespo-Soto C.
Emergencias. 2017 Jul;29(4):245-248.
[Diagnosis and assessment of hypoglycemia in patients with diabetes mellitus].
Scheen AJ.
Rev Med Liege. 2014 Feb;69(2):110-5.
Analysis of Risk Factors for Hypoglycemic Coma in 194 Patients with Type 2 Diabetes.
Lu Z, Liu J, He Q, Chakraborty A, Zhu T.
Med Sci Monit. 2017 Nov 28;23:5662-5668. doi: 10.12659/msm.902748.
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV.
N Engl J Med. 2000 Jul 27;343(4):230-8. doi: 10.1056/NEJM200007273430401.
Decreased vascular endothelial growth factor response to acute hypoglycemia in type 2 diabetic patients with hypoglycemic coma.
Arnalich F, Maldifassi MC, Atienza G, Ciria E, Quesada A, Cedillo JL, Renart J, Codoceo R, Herruzo R, Montiel C.
Cytokine. 2012 Mar;57(3):372-8. doi: 10.1016/j.cyto.2011.12.003. Epub 2011 Dec 29.
Anti-interleukin-21 antibody and liraglutide for the preservation of beta-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
von Herrath M, Bain SC, Bode B, Clausen JO, Coppieters K, Gaysina L, Gumprecht J, Hansen TK, Mathieu C, Morales C, Mosenzon O, Segel S, Tsoukas G, Pieber TR; Anti-IL-21–liraglutide Study Group investigators and contributors.
Lancet Diabetes Endocrinol. 2021 Apr;9(4):212-224. doi: 10.1016/S2213-8587(21)00019-X. Epub 2021 Mar 1.
